Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04590508
PHASE2

A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease

Sponsor: National University of Natural Medicine

View on ClinicalTrials.gov

Summary

A pilot study to assess the safety and tolerability of an orally administered natural product derived from hops, called xanthohumol, in humans with Crohn's Disease, in order to identify a biological signature of xanthohumol exposure, and to characterize the role of xanthohumol metabolism by intestinal microorganisms in that signature within adults with Crohn's Disease.

Key Details

Gender

All

Age Range

21 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2020-10-01

Completion Date

2025-07-30

Last Updated

2024-10-18

Healthy Volunteers

No

Conditions

Interventions

DRUG

Xanthohumol

The xanthohumol supplement will be administered in a capsule and taken orally.

OTHER

Placebo

The placebo will be administered in a capsule and taken orally.

Locations (1)

National University of Natural Medicine

Portland, Oregon, United States